Skip to main content
main-content

03.01.2019 | Laryngology | Ausgabe 2/2019

European Archives of Oto-Rhino-Laryngology 2/2019

A new approach to vocal cord leukoplakia and evaluation of proton pump ınhibitor treatment

Zeitschrift:
European Archives of Oto-Rhino-Laryngology > Ausgabe 2/2019
Autoren:
Seda Sezen Goktas, Remzi Dogan, Alper Yenigun, Omer Faruk Calim, Orhan Ozturan, Selahattin Tugrul

Abstract

Purpose

Our aim is identify a new approach to vocal cord leukoplakia treatment and detect to efficiency of proton pump inhibitors.

Study design

Prospective, nonrandomized experimental clinical trial.

Methods

A ‘First Assessment Scale’ was prepared. This scale included the lesion’s and the patient’s characteristics. Using this scale, 24 patients included to the study. 20 mg rabeprazole twice daily was applied to all patients. At the end of 3rd month, a ‘Second Assessment Scale’ was used and two groups created. In group 1, 19 patients were accepted to responsive for the therapy and received the same therapy. The group 2 was included five patients that accepted unresponsive to treatment and directed to surgery. All patients received the same treatment additionally 3 months. At the end of 6th month, the Reflux Symptom Index (RSI), the Reflux Finding Score (RFS) and the Red–Green–Blue (RGB) values evaluated and comparisons were made.

Results

The RSI and RFS values were significantly decreased in all patients. The Red values were significantly decreased with treatment in group 1, but the Green and Blue values were not. In group 2, the RGB values were not showed the significant differences. In conclusion, seven patients (29,2%) showed complete lesion regression, 12 patients (50%) showed partial lesion regression and five patients (20,8%) showed no response to treatment.

Conclusions

The proton pump inhibitor treatment may be beneficial for the selected patients. The scales that we prepared were useful for lesion assesment.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 2/2019

European Archives of Oto-Rhino-Laryngology 2/2019 Zur Ausgabe
  1. Sie können e.Med HNO 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

Neu im Fachgebiet HNO

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update HNO und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise